☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Completion
Mallinckrodt Reports Completion of BLA Submission to the US FDA for StrataGraft to Treat Deep Partial-Thickness Thermal Burns in A...
June 9, 2020
Esperion Reports Completion of Bempedoic Acid in Global P-III LDL-C Development Program for Patients with ASCVD or HeFH
October 29, 2018
Allergan Announces Completion of UBR-MD-04 & 3110-105-002 Study for Treatment of Migrane
October 18, 2018
Emergent BioSolutions Announces Completion of Acquisition of PaxVax for ~$270M
October 5, 2018
First Generic approved by FDA using Competitive Generic Pathway (CGT) to Foster Competition for sole source drugs
August 8, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.